Effect of an Electronic Reminder System on Direct Oral Anticoagulant and Oral Diabetes Medication Adherence

Helsinki University Central Hospital (HUCH)

Status: Unknown

Conditions: Diabetes Mellitus, Type 2; Anticoagulant Drugs

Treatments: Device: Electronic medicine reminder system

Study type: Interventional

Funder types: Other

Identifiers

NCT03753568

002

Details and patient eligibility

About

In this study, the effect of an electronic device attached to a push through pill package and a smart phone application on chronic disease medication adherence is studied.

Full description

In this study study two different groups of medicine users are recruited. Both groups have 50 patients each. In the first study the participants are using oral medication for diabetes and in the second study the participants use new direct oral anticoagulants.

Participants use medicine reminder system consisting of an electronic device and an smart phone application. In the beginning of the study the reminder system is collecting data on how the patients are taking their medication for the first two months. Smart phone application is not providing any reminders and participants can't access the app to see the details.

After two months the application will be unlocked so that it starts reminding the users to take their medication at the right time. in this phase the patients can view their medication data from the application. The reminder phase of the study lasts for two months. After these two plus two months, the results are analyzed and published.

The study continues after these four months for the next four months and after that, the long term results are analyzed.'

The primary outcome is the possible change in the adherence between control and active period.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• use of direct oral anticoagulants or oral diabetic drugs
• age of 18 or more
• subjects have been using a smart phone

Exclusion criteria

• patients who don't use their medication without help

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

100 participants in 1 patient group

Study group

Experimental group

Description:

The participants use either direct oral anticoagulants or oral diabetic medication.

Treatment:

Device: Electronic medicine reminder system